Blepharospasm is a condition that is characterized by involuntary movements of the eyelids. Tics and twitches around the eye area are common, but in severe cases this can inhibit the ability of an ...
CORONADO, California — Patients with blepharospasm can wait more than 2 years to receive a correct diagnosis, according to a new survey. "There's no excuse," said researcher Kristen Dunbar, MD, a ...
RALEIGH, N.C.--(BUSINESS WIRE)--Merz Americas announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for XEOMIN ® ...
Cannabis oil may reduce the duration and frequency of spasms caused by benign essential blepharospasm (eye twitching), researchers say. The treatment could serve as a second-line treatment for ...
A fascinating new study published in the latest edition of Movements Disorders (Vol.00 No.00, 2016) presents two patient case studies that demonstrate how speaking French as a second language can ...
Blepharospasm, also referred to as benign essential blepharospasm, is a rare condition that possibly goes undiagnosed or misdiagnosed. Botulinum toxin is the only FDA -approved medication for the ...
Please provide your email address to receive an email when new articles are posted on . Coffee drinkers are less likely to develop primary late onset blepharospasm, according to a study by researchers ...
The FDA has approved Xeomin (incobotulinumtoxinA; Merz) as a first-line treatment for blepharospasm in adults. The Food and Drug Administration (FDA) has approved Xeomin (incobotulinumtoxinA; Merz) as ...
Spastic lower lid entropion: before (top) and after (bottom) botulinum toxin injection. SAN DIEGO – Botulinum toxin has other uses beyond blepharospasm and its recently approved cosmetic applications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback